Stay updated on Durvalumab and Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelimumab in NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Added a site-wide notice about potential delays due to a lapse in government funding and the NIH Clinical Center’s open status, and updated the page revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T04:58:24.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    UI updates add a Show glossary option and explain color-coding for additions/deletions (green/red), and the page revision label shifts from v3.3.4 to v3.4.0 with capitalization tweaks in 'No FEAR Act data'.
    Difference
    0.5%
    Check dated 2026-01-28T03:14:22.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the Record History page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:14:37.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Added a site-wide revision note (Revision: v3.3.3) and removed the HHS Vulnerability Disclosure link along with Revision: v3.3.2; these are UI/policy updates and do not alter the clinical trial record data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T09:59:16.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.2, replacing Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:27:45.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added and revision: v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-24T13:43:19.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.